Theriva Biologics, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Theriva Biologics, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2019-12-31 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2019-09-30 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2019-06-30 was 0.00 shares.
- Theriva Biologics, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2019-03-31 was 3.70M shares.
- Theriva Biologics, Inc. stock issued during period, shares, reverse stock splits for fiscal 2019 was 3.70M shares, a 0.00% change from fiscal 2018.
- Theriva Biologics, Inc. stock issued during period, shares, reverse stock splits for fiscal 2018 was 3.70M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits 3 month | Stock Issued During Period, Shares, Reverse Stock Splits 12 month |
|---|---|---|
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 3.70M shares 10-K · filed 2020-02-20 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | |
| 2019-03-31 | 3.70M shares 10-Q · filed 2019-05-08 | |
| 2018-12-31 | 3.70M shares 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |